The CA of JA3 WP4 on “Antibacterial-coated Sutures Versus Non-Antibacterial-Coated Sutures for the Prevention of Abdominal, Superficial and Deep Incisional, Surgical Site Infection (SSI)” is now available.
We are pleased to announce that the collaborative rapid assessment of JA3 WP4 on “ANTIBACTERIAL-COATED SUTURES VERSUS NON-ANTIBACTERIAL-COATED SUTURES FOR THE PREVENTION OF ABDOMINAL, SUPERFICIAL AND DEEP INCISIONAL, SURGICAL SITE INFECTION (SSI)” is available.
Surgical site infection (SSI) is a frequent type of nosocomial infection, accounting for about 14% to 15% of the total number of nosocomial infections and roughly 5% of all surgical complications. Antibacterial-coated sutures are developed with the aim to reduce the risk of SSI by minimising the risk of colonisation of the suture by bacteria commonly associated with such infections. Surgical sutures coated with triclosan and surgical sutures coated with chlorhexidine are currently on the market, and some others are in the development phase.
The objective of this rapid assessment was to evaluate the effectiveness and safety of antibacterial-coated sutures for the prevention of superficial and deep incisional surgical site infection (SSI), compared with non-antibacterial coated sutures, in abdominal surgery in adults.
Final version of the assessment was published in April 2017
Below is the documentation provided by the assessment authoring team:
OTCA02_Antibacterial coated sutures for the prevention of abdominal SSI_0
Antibacterial-coated sutures for the prevention of abdominal SSI_external comments on draft assessment_2
Antibacterial-coated sutures for the prevention of abdominal SSI_external comments on draft Project Plan_3